Exploring Natural Immune Responses to Shigella Exposure Using Multiplex Bead Assays on Dried Blood Spots in High-Burden Countries: Protocol From a Multisite Diarrhea Surveillance Study

Benedicto-Matambo P.; Avolio L.N.; Badji H.; Batool R.; Khanam F.; Munga S.; Tapia M.D.; Yori P.P.; Awuor A.O.; Ceesay B.E.; Cornick J.; Cunliffe N.A.; Garcia Bardales P.F.; Heaney C.D.; Hotwani A.; Ireen M.; Islam M.T.; Jallow O.; Kaminski R.W.; Shapiama Lopez W.V.; Maiden V.; Ikumapayi U.N.; Nyirenda R.; Ochieng J.B.; Omore R.; Olortegui M.P.; Pavlinac P.B.; Pisanic N.; Qadri F.; Qureshi S.; Rahman N.; Rogawski McQuade E.T.; Schiaffino F.; Secka O.; Sonye C.; Sultana S.; Timite D.; Traore A.; Yousafzai M.T.; Bhuiyan M.T.R.; Jahangir Hossain M.; Jere K.C.; Kosek M.N.; Kotloff K.L.; Qamar F.N.; Sow S.O.; Platts-Mills J.A. · Open Forum Infectious Diseases (2024) · DOI: 10.1093/ofid/ofad650

Resumen

Background. Molecular diagnostics on human fecal samples have identified a larger burden of shigellosis than previously appreciated by culture. Evidence of fold changes in immunoglobulin G (IgG) to conserved and type-specific Shigella antigens could be used to validate the molecular assignment of type-specific Shigella as the etiology of acute diarrhea and support polymerase chain reaction (PCR)–based microbiologic end points for vaccine trials. Methods. We will test dried blood spots collected at enrollment and 4 weeks later using bead-based immunoassays for IgG to invasion plasmid antigen B and type-specific lipopolysaccharide O-antigen for Shigella flexneri 1b, 2a, 3a, and 6 and Shigella sonnei in Shigella-positive cases and age-, site-, and season-matched test-negative controls from all sites in the Enterics for Global Health (EFGH) Shigella surveillance study. Fold antibody responses will be compared between culture-positive, culture-negative but PCR-attributable, and PCR-positive but not attributable cases and test-negative controls. Age- and site-specific seroprevalence distributions will be identified, and the association between baseline antibodies and Shigella attribution will be estimated. Conclusions. The integration of these assays into the EFGH study will help support PCR-based attribution of acute diarrhea to type-specific Shigella, describe the baseline seroprevalence of conserved and type-specific Shigella antibodies, and support correlates of protection for immunity to Shigella diarrhea. These insights can help support the development and evaluation of Shigella vaccine candidates. © The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

Instituciones: Universidad Peruana Cayetano Heredia